Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Immunology and Allergy ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Food allergy among U.S. children: trends in prevalence and hospitalizations.NCHS Data Brief. 2008; : 1-8
- The prevalence, severity, and distribution of childhood food allergy in the United States.Pediatrics. 2011; 128: e9-e17
- Prevalence and severity of food allergies among US adults.JAMA Netw open. 2019; 2: e185630
- Food allergy: epidemiology, pathogenesis, diagnosis, and treatment.J Allergy Clin Immunol. 2014; 133 ([quiz: 308]): 291-307
- The emotional, social, and financial burden of food allergies on children and their families.Allergy Asthma Proc. 2017; 38: 88-91
- The heterogeneity of oral immunotherapy clinical trials: implications and future directions.Curr Allergy Asthma Rep. 2016; 16: 25
- AR101 oral immunotherapy for peanut allergy.N Engl J Med. 2018; 379: 1991-2001
- Effect of epicutaneous immunotherapy vs placebo on reaction to peanut protein ingestion among children with peanut allergy: the PEPITES randomized clinical trial.JAMA. 2019; 321: 946-955
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.J Allergy Clin Immunol. 2014; 133: 468-475
- Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).J Allergy Clin Immunol. 2014; 133: 500-510
- Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety.Lancet. 2019; 393: 2222-2232
- The role of the gut microbiota in food allergy.Curr Opin Pediatr. 2016; 28: 748-753
- Commensal bacteria protect against food allergen sensitization.Proc Natl Acad Sci U S A. 2014; 111: 13145-13150
- Microbiota therapy acts via a regulatory T cell MyD88/RORgammat pathway to suppress food allergy.Nat Med. 2019; 25: 1164-1174
- The future of biologics: applications for food allergy.J Allergy Clin Immunol. 2015; 135: 312-323
- New treatment directions in food allergy.Ann Allergy Asthma Immunol. 2018; 120: 254-262
- Characterization of complex formation by humanized anti-IgE monoclonal antibody and monoclonal human IgE.Biochemistry. 1995; 34: 10474-10482
- Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy.J Allergy Clin Immunol. 2012; 130: 1123-1129.e2
- A phase II, randomized, doubleblind, parallelgroup, placebocontrolled oral food challenge trial of Xolair (omalizumab) in peanut allergy.J Allergy Clin Immunol. 2011; 127: 1309-1310.e1
- Impact of omalizumab on food allergy in patients treated for asthma: a real-life study.J Allergy Clin Immunol Pract. 2019; 7: 1901-1909.e5
- Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy.J Allergy Clin Immunol. 2011; 127: 1622-1624
- Omalizumab facilitates rapid oral desensitization for peanut allergy.J Allergy Clin Immunol. 2017; 139: 873-881.e8
- A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.J Allergy Clin Immunol. 2013; 132: 1368-1374
- A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.J Allergy Clin Immunol. 2016; 137: 1103-1110.e11
- Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab.Allergy Asthma Clin Immunol. 2017; 13: 51
- Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial.Lancet. 2018; 3: 85-94
- New biologics in the treatment of urticaria.Curr Opin Allergy Clin Immunol. 2018; 18: 425-431
- Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy.J Allergy Clin Immunol. 2010; 125: 1077-1083.e8
- IL13 variants are associated with total serum IgE and early sensitization to food allergens in children with atopic dermatitis.Pediatr Allergy Immunol. 2009; 20: 551-555
- Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.N Engl J Med. 2014; 371: 130-139
- Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma.N Engl J Med. 2018; 378: 2475-2485
- Efficacy and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps: results from the randomized phase 3 sinus-24 study.J Allergy Clin Immunol. 2019; 143: AB422
- Oral immunotherapy with omalizumab reverses the Th2 cell-like programme of regulatory T cells and restores their function.Clin Exp Allergy. 2018; 48: 825-836
- Dupilumab for treatment of food allergy.J Allergy Clin Immunol Pract. 2019; 7: 673-674
- Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis.J Allergy Clin Immunol. 2015; 135: 500-507
- Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials.Lancet Respir Med. 2016; 4: 781-796
- Meta-analysis of randomized controlled trials for the efficacy and safety of anti-interleukin-13 therapy with lebrikizumab in patients with uncontrolled asthma.Allergy Asthma Proc. 2018; 39: 332-337
- Anti-IL5 therapies for asthma.Cochrane Database Syst Rev. 2017; (CD010834)
- Monoclonal antibodies for severe asthma: pharmacokinetic profiles.Respir Med. 2019; 153: 3-13
- Emerging therapies for food allergy.J Clin Invest. 2014; 124: 1880-1886
- Oral sensitization to peanut is highly enhanced by application of peanut extracts to intact skin, but is prevented when CpG and cholera toxin are added.Int Arch Allergy Immunol. 2007; 143: 10-20
- Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice.Mol Nutr Food Res. 2013; 57: 906-915
- Co-delivery of ovalbumin and CpG motifs into microparticles protected sensitized mice from anaphylaxis.Int Arch Allergy Immunol. 2009; 149: 111-118
- CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway.Int Immunopharmacol. 2008; 8: 351-361
- Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.N Engl J Med. 2006; 355: 1445-1455
- Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.J Allergy Clin Immunol. 2004; 113: 235-241
- Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen.J Allergy Clin Immunol. 2014; 133: 121-129.e1-2
- Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: a phase I/IIa study.Int Arch Allergy Immunol. 2011; 154: 336-344
- Ultra-short course immunotherapy in children and adolescents during a 3-yrs post-marketing surveillance study.Pediatr Allergy Immunol. 2010; 21: e185-e189
- Glucopyranosyl Lipid a (GLA) a Toll-like receptor 4 (TLR4) agonist for use as an adjuvant in combination with peanut allergen immunotherapy.J Allergy Clin Immunol. 2016; 137: AB129
- Oral administration of chitin and chitosan prevents peanut-induced anaphylaxis in a murine food allergy model.Int J Biol Macromol. 2013; 61: 164-168
- Intestinal mucosal barrier function in health and disease.Nat Rev Immunol. 2009; 9: 799-809
- IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization.J Allergy Clin Immunol. 2013; 131: 187-200.e1-8
- TSLP promotes induction of Th2 differentiation but is not necessary during established allergen-induced pulmonary disease.PLoS One. 2013; 8: e56433
- Tezepelumab in adults with uncontrolled asthma.N Engl J Med. 2017; 377: 936-946
- Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial.J Am Acad Dermatol. 2019; 80: 1013-1021
- DNA vaccines: an historical perspective and view to the future.Immunol Rev. 2011; 239: 62-84
- CryJ-LAMP DNA vaccines for Japanese red cedar allergy induce robust Th1-type immune responses in murine model.J Immunol Res. 2016; 2016: 4857869
- A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy.Allergy. 2013; 68: 803-808
- The potential link between gut microbiota and IgE-mediated food allergy in early life.Int J Environ Res Public Health. 2013; 10: 7235-7256
- Effect of Lactobacillus GG on tolerance acquisition in infants with cow's milk allergy: a randomized trial.J Allergy Clin Immunol. 2012; 129 (582.e1-5): 580-582
- The acquisition of tolerance toward cow's milk through probiotic supplementation: a randomized, controlled trial.J Allergy Clin Immunol. 2008; 121: 1448-1454
- Probiotics for prevention of atopy and food hypersensitivity in early childhood: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials.Medicine (Baltimore). 2016; 95: e2562
- Administration of a probiotic with peanut oral immunotherapy: a randomized trial.J Allergy Clin Immunol. 2015; 135: 737-744.e8
- Duodenal infusion of donor feces for recurrent Clostridium difficile.N Engl J Med. 2013; 368: 407-415
- Healthy infants harbor intestinal bacteria that protect against food allergy.Nat Med. 2019; 25: 448-453
- Effect of anti-IgE therapy in patients with peanut allergy.N Engl J Med. 2003; 348: 986-993
- Short-term ibrutinib therapy suppresses skin test responses and eliminates IgE-mediated basophil activation in adults with peanut or tree nut allergy.J Allergy Clin Immunol. 2018; 141: 1914-1916.e7
- Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cow's milk allergy: 3-year randomized controlled trial.J Allergy Clin Immunol. 2017; 139: 1906-1913.e4
Article info
Footnotes
Disclosure Statement: The authors have nothing to disclose.
Identification
Copyright
© 2019 Elsevier Inc. All rights reserved.
